Trial intelligence / Profile preview

Botulinum toxin type A for chronic neck pain after whiplash: phase IV randomized double-blind placebo-controlled pilot study

2004-004589-33Phase 4Active

Sponsor
Hospital Mútua de Terrassa Rehabilitation Department
Start
Jul 2006
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 4, randomised, double-blind trial in cervicalgia and Whiplash Associated Disorder (WAD) comparing Botox with Placebo (2 arms). Primary endpoint: Improvement in pain using visual analog scale. Started Jul 2006; status: active.

02

Drugs

botulinum toxin type A
03

Conditions

cervicalgiaWhiplash Associated Disorder (WAD)

Beyond the preview

Go deeper on 2004-004589-33.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2004-004589-33.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call